Blockade of opiate receptors with naloxone improves survival and cardiac performance in canine endotoxic shock.
D000818:Animals; D002302:Cardiac Output / Q000187:drug effects; D002319:Cardiovascular System / Q000503:physiopathology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D004731:Endotoxins; D005260:Female; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects; D008297:Male; D008638:Mesenteric Arteries / Q000503:physiopathology; D009270:Naloxone / Q000627:therapeutic use*; D011957:Receptors, Opioid / Q000187:drug effects*; D012769:Shock / Q000188:drug therapy* / Q000209:etiology / Q000401:mortality; D014655:Vascular Resistance / Q000187:drug effects; D014690:Venous Pressure / Q000187:drug effects
D004731:Endotoxins; D011957:Receptors, Opioid; D009270:Naloxone